In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing IMRT
Authors:
- 22 September 2006
- journal article
- Published by Wiley in Medical Physics
- Vol. 33 (10) , 3734-3742
Abstract
For intensity modulated radiation therapy (IMRT) treatments photons are typically used, however, for deep seated tumors in the pelvic region, higher photon energies are increasingly being employed. IMRT treatments require more monitor units (MU) to deliver the same dose as conformal treatments, causing increased secondary radiation to tissues outside the treated area from leakage and scatter, as well as a possible increase in the neutron dose from photon interactions in the machine head. Here we provide in vivo patient and phantom measurements of the secondary out‐of‐field photon radiation and the neutron dose equivalent for IMRT treatments. The patients were treated for prostate cancer with IMRT at institutions using different therapy machines and treatment planning systems. Phantom exposures at the different facilities were used to compare the secondary photon and neutron dose equivalent between typical IMRT delivered treatment plans with a six field three‐dimensional conformal radiotherapy (3DCRT) plan. For the in vivo measurements thermoluminescent detectors (TLDs) and detectors using optically stimulated radiation were used to obtain the photon dose and CR‐39 track etch detectors were used to obtain the neutron dose equivalent. For the phantom measurements a Bonner sphere ( diameter) containing two types of TLDs (TLD‐600 and TLD‐700) having different thermal neutron sensitivities were used to obtain the out‐of‐field neutron dose equivalent. Our results showed that for patients treated with IMRT the photon dose equivalent is greater than the neutron dose equivalent measured outside the treatment field and the neutron dose equivalent normalized to the prescription dose varied from 2 to among the therapy machines. The Bonner sphere results showed that the ratio of neutron equivalent doses for the IMRT and 3DCRT prostate treatments scaled as the ratio of delivered MUs. We also observed differences in the measured neutron dose equivalent among the three therapy machines for both the in vivo and phantom exposures.Keywords
This publication has 23 references indexed in Scilit:
- IMRT treatment planning—A comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO groupRadiotherapy and Oncology, 2005
- A study of neutron spectra from medical linear acceleratorsApplied Radiation and Isotopes, 2005
- Characterization of Al2O3 single crystals grown by the laser-heated pedestal growth technique for potential use in radiation dosimetryRadiation Measurements, 2003
- Individual Neutron Monitoring with CR-39 Detectors at an Accelerator CentreRadiation Protection Dosimetry, 1999
- Specification of Bonner Sphere Systems for Neutron SpectrometryRadiation Protection Dosimetry, 1997
- The Neutron Response of AL2O3:C, 7LiF:Mg,Cu,P and 7LiF:Mg,Ti TLDsRadiation Protection Dosimetry, 1996
- Photoneutrons from medical linear accelerators—Radiobiological measurements and risk estimatesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Neutron contamination of X-ray beams produced by the Varian Clinac 1800Physics in Medicine & Biology, 1989
- Neutrons from high‐energy x‐ray medical accelerators: An estimate of risk to the radiotherapy patientMedical Physics, 1984
- Neutron dosimetry in high energy X-ray beams of medical acceleratorsPhysics in Medicine & Biology, 1979